EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered cyclic peptide targeting ITGA5 disrupts tumor–stroma interaction to overcome desmoplasia and resistance in pancreatic ductal adenocarcinoma

Deby Fajar Mardhian, Kunal P Pednekar, Ahmed G Hemdan, Praneeth Reddy Kuninty, Saadia A Karim, Sabine de Winter, Josbert M Metselaar, Jennifer P Morton, Jai Prakash

Acta Pharmaceutica Sinica B · 2026-01 · 16 (1) · 305-321

DOI: 10.1016/j.apsb.2025.10.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-01. Verfasst von Deby Fajar Mardhian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Engineered Therapeutics Group, Department of Advanced Organ Bioengineering and Therapeutics, Faculty of Science and Technology, University of Twente,…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Technology Foundation STW, Egypt Ministry of Higher Education Cultural Affairs and Missions Sector.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cancer-associated fibroblastsFibronectinITGA5Pancreatic cancerPancreatic stellate cellsPeptideTumor microenvironmentcyAV3.3

Autor:innen und Institutionen

  • Engineered Therapeutics Group, Department of Advanced Organ Bioengineering and Therapeutics, Faculty of Science and Technology, University of Twente, Enschede 7500AE, The Netherlands.
  • Department of Dental Materials and Technology, Faculty of Dentistry, Padjadjaran University, Bandung 40132, Indonesia.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
  • CRUK Scotland Institute, Glasgow G61 1BD, UK.
  • ScarTec Therapeutics BV, Horst 2, Enschede 7522LW, The Netherlands.
  • Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Hospital, Aachen 52074, Germany.

Förderung

  • Swedish Research Council
  • Technology Foundation STW
  • Egypt Ministry of Higher Education Cultural Affairs and Missions Sector
  • Lembaga Pengelola Dana Pendidikan
  • Cancer Research UK
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Ministry of Higher Education and Scientific Research

Zitieren

APA

Mardhian, D. F., Pednekar, K. P., Hemdan, A. G., Kuninty, P. R., Karim, S. A., de Winter, S., Metselaar, J. M., Morton, J. P., & Prakash, J. (2026). Engineered cyclic peptide targeting ITGA5 disrupts tumor–stroma interaction to overcome desmoplasia and resistance in pancreatic ductal adenocarcinoma. Acta Pharmaceutica Sinica B, 16(1), 305-321. https://doi.org/10.1016/j.apsb.2025.10.022

Vancouver

Mardhian DF, Pednekar KP, Hemdan AG, Kuninty PR, Karim SA, de Winter S, et al. Engineered cyclic peptide targeting ITGA5 disrupts tumor–stroma interaction to overcome desmoplasia and resistance in pancreatic ductal adenocarcinoma. Acta Pharmaceutica Sinica B. 2026;16(1):305-321. doi:10.1016/j.apsb.2025.10.022

BibTeX
@article{Mardhian2026,
  author = {Mardhian, Deby Fajar and Pednekar, Kunal P and Hemdan, Ahmed G and Kuninty, Praneeth Reddy and Karim, Saadia A and de Winter, Sabine and Metselaar, Josbert M and Morton, Jennifer P and Prakash, Jai},
  title = {Engineered cyclic peptide targeting ITGA5 disrupts tumor–stroma interaction to overcome desmoplasia and resistance in pancreatic ductal adenocarcinoma},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {305--321},
  doi = {10.1016/j.apsb.2025.10.022}
}
Kostenlos starten →